Advertisement

Transcriptome sequencing of endometrium revealed alterations in mRNAs and lncRNAs after ovarian stimulation

  • Lingxiu Li
  • Peng Wang
  • Shan Liu
  • Xueyan Bai
  • Binbin Zou
  • Yuan LiEmail author
Assisted Reproduction Technologies

Abstract

Research question

Using RNA-sequencing analysis, we investigated the relationship between ovarian stimulation and endometrial transcriptome profiles during the window of implantation (WOI) to identify candidate predictive factors for the WOI and to optimize timing for embryo transfer.

Methods

Twelve women with normal basal hormone levels and regular ovulation were randomly assigned into three groups based on sampling time: late-proliferate phase (P group), and receptive phase in natural cycles (LH+7, N group) and stimulated cycles (hCG+7, S group). Transcriptome profiles of mRNAs and long non-coding RNAs (lncRNAs) were then compared among the three groups. Validation was performed using real-time qPCR.

Results

Comparison of transcriptome profiles between the natural and stimulated endometrium revealed 173 differentially expressed genes (DEGs), with a > 2-fold change (FC) and p < 0.05, under the influence of supraphysiological estradiol (E2) induced by ovarian stimulation. By clustering and KEGG pathway analysis, molecules and pathways associated with endometrial receptivity were identified. Of the 39 DEGs common to the three groups, eight genes were validated using real-time PCR. ESR1, MMP10, and HPSE were previously reported to be associated with endometrial receptivity. In addition, three novel genes (IL13RA2, ZCCHC12, SRARP) and two lncRNAs (LINC01060, LINC01104) were new potential endometrial receptivity-related markers.

Conclusion

Using mRNA and lncRNA sequencing, we found that supraphysiological E2 levels from ovarian stimulation had a marked impact upon endometrial transcriptome profiles and may result in a shift of the WOI. The precise mechanisms underlying the supraphysiological hormone-induced shift of the WOI require further research.

Registration number

ChiCTR180001453

Keywords

Ovarian stimulation Window of implantation Endometrial receptivity mRNAs lncRNAs 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

10815_2019_1616_MOESM1_ESM.rar (2.7 mb)
ESM 1 (RAR 2715 kb)

References

  1. 1.
    Zhang S, Lin H, Kong S, Wang S, Wang H, Wang H, et al. Physiological and molecular determinants of embryo implantation. Mol Asp Med. 2014;34:939–80.CrossRefGoogle Scholar
  2. 2.
    Norwitz ER, Schust DJ, Fisher JS. Implantation and the survival of early pregnancy. N Engl J Med. 2001;345:1400–8.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Rachel SMD. The receptivity of the endometrium to implementation. Journal of Obstetrics & Gynaecology of the British Empire. 2010;69(1):107–9.Google Scholar
  4. 4.
    Paulson RJ. Hormonal induction of endometrial receptivity. Fertil Steril. Elsevier Ltd; 2011;96:530–5.  https://doi.org/10.1016/j.fertnstert.2011.07.1097 PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Macklon NS, Geraedts JPM, Fauser BCJM. Conception to ongoing pregnancy: The “black box” of early pregnancy loss. Hum Reprod Update. 2002;8:333–43.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Kumar P, Sharma A. Understanding implantation window, a crucial phenomenon. J Hum Reprod Sci. 2012;5:2. Available from: https://www.jhrsonline.org/text.asp?2012/5/1/2/97777 .PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Pellicer A, Valbuena D, Cano F, Remohi J, Simon C. Lower implantation rates in high responders: Evidence for an altered endocrine milieu during the preimplantation period. Fertil Steril. 1996;65:1190–5.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Evans J, Hannan NJ, Edgell TA, Vollenhoven BJ, Lutjen PJ, Osianlis T, et al. Fresh versus frozen embryo transfer: Backing clinical decisions with scientific and clinical evidence. Hum Reprod Update. 2014;20:808–21.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Ozkaya E, Kutlu T, Yayla CA, et al. Area under the curve of temporal estrogen and progesterone measurements during assisted reproductive technology: Which hormone is the main determinant of cycle outcome? Journal of Obstetrics and Gynaecology Research. 2018;44(2):263–9.PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Basir GS, Wai-sum O, Ng EHY, Ho PC. Morphometric analysis of peri-implantation endometrium in patients having excessively high oestradiol concentrations after ovarian stimulation. Hum Reprod. 2001;16:435–40.PubMedCrossRefPubMedCentralGoogle Scholar
  11. 11.
    Bourgain C, Devroey P. The endometrium in stimulated cycles for IVF. Hum Reprod Update. 2003;9:515–22.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Nikas G. Endometrial receptivity: Changes in cell-surface morphology. Semin Reprod Med. 2000;18:229–35.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Hsiu JG, Toner JP, Oehninger S, Jones HW. Endometrial estrogen and progesterone receptor and pinopode expression in stimulated cycles of oocyte donors. Fertil Steril. 1999;71:1040–7.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Valdez-Morales FJ, Domà nguez AG, Vital-Reyes VS, Hinojosa Cruz JC, Chimal-Monroy J, Franco-Murillo Y, et al. Changes in receptivity epithelial cell markers of endometrium after ovarian stimulation treatments: Its role during implantation window. Reprod Health. 2015;12:1–11.CrossRefGoogle Scholar
  15. 15.
    Boomsma CM, Kavelaars A, Eijkemans MJC, Fauser BCJM, Heijnen CJ, MacKlon NS. Ovarian stimulation for in vitro fertilization alters the intrauterine cytokine, chemokine, and growth factor milieu encountered by the embryo. Fertil Steril. Elsevier Ltd; 2010;94:1764–8.  https://doi.org/10.1016/j.fertnstert.2009.10.044 PubMedCrossRefPubMedCentralGoogle Scholar
  16. 16.
    Chen Q j, Sun X x, Li L, Gao X h, Gemzell-Danielsson K, Cheng L n. Effects of ovarian stimulation on endometrial integrin β3 and leukemia inhibitory factor expression in the peri-implantation phase. Fertil Steril. 2008;89:1357–63.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Thomas K, Thomson AJ, Sephton V, Cowan C, Wood S, Vince G, et al. The effect of gonadotrophic stimulation on integrin expression in the endometrium. Hum Reprod 2002;17:63–68. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=11756363&retmode=ref&cmd=prlinks%5Cnpapers2://publication/uuid/D41C33EE-8D6D-4CFC-86A6-FAD09F5B5F19 (Accessed: 15 June 2017)
  18. 18.
    Bourgain C, Ubaldi F, Tavaniotou A, Smitz J, Van Steirteghem AC, Devroey P. Endometrial hormone receptors and proliferation index in the periovulatory phase of stimulated embryo transfer cycles in comparison with natural cycles and relation to clinical pregnancy outcome. Fertil Steril. 2002;78:237–44.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Altmae S, Martinez-Conejero JA, Salumets A, Simon C, Horcajadas JA, Stavreus-Evers A. Endometrial gene expression analysis at the time of embryo implantation in women with unexplained infertility. Mol Hum Reprod. 2010;16:178–87. Available from: https://academic.oup.com/molehr/article-lookup/doi/10.1093/molehr/gap102 .PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Kuokkanen S, Chen B, Ojalvo L, Benard L, Santoro N, Pollard JW. Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol Reprod. 2010;82:791–801. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19864316 .PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Ponnampalam AP, Weston GC, Susil B, Rogers PAW. Molecular profiling of human endometrium during the menstrual cycle. Aust N Z J Obstet Gynaecol. 2006;46:154–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16638040 .PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Ponnampalam AP, Weston GC, Trajstman AC, Susil B, Rogers PAW. Molecular classification of human endometrial cycle stages by transcriptional profiling. Mol Hum Reprod. 2004;10:879–93.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Horcajadas JA, Riesewijk A, Martin J, Cervero A, Mosselman S, Pellicer A, et al. Global gene expression profiling of human endometrial receptivity. J Reprod Immunol. 2004;63:41–9.PubMedCrossRefPubMedCentralGoogle Scholar
  24. 24.
    Borthwick JM, Charnock-jones DS, Tom BD, Hull ML, Teirney R, Phillips SC, et al. Determination of the transcript pro ® le of human endometrium. Mol Hum Reprod. 2003;9:19–33. Available from: http://molehr.oxfordjournals.org/content/9/1/19.long .
  25. 25.
    Riesewijk A, Martin J, van Os R, Horcajadas JA, Polman J, Pellicer A, et al. Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology. Mol Hum Reprod. 2003;9:253–64. Available from: http://molehr.oxfordjournals.org/cgi/content/abstract/9/5/253 .PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Kao L, Tulac S, Lobo S, Imani B. Global gene profiling in human endometrium during the window of implantation. … [Internet]. 2002;143:2119–38. Available from: http://press.endocrine.org/doi/abs/10.1210/endo.143.6.8885 (Accessed: 23 October 2016)PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Carson DD. Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol Hum Reprod . 2002;8:871–879. Available from: http://molehr.oxfordjournals.org/content/8/9/871.short PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Mirkin S, Nikas G, Hsiu JG, Díaz J, Oehninger S. Gene expression profiles and structural/functional features of the peri-implantation endometrium in natural and gonadotropin-stimulated cycles. J Clin Endocrinol Metab. 2004;89:5742–52.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Macklon NS, Van Der Gaast MH, Hamilton A, Fauser BCJM, Giudice LC. The Impact of Ovarian Stimulation With Recombinant. :357–65.Google Scholar
  30. 30.
    Haouzi D, Assou S, Mahmoud K, Tondeur S, Rème T, Hedon B, et al. Gene expression profile of human endometrial receptivity: Comparison between natural and stimulated cycles for the same patients. Hum Reprod. 2009;24:1436–45.PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Liu Y, Lee KF, Ng EHY, Yeung WSB, Ho PC. Gene expression profiling of human peri-implantation endometria between natural and stimulated cycles. Fertil Steril. Elsevier Ltd; 2008;90:2152–64.  https://doi.org/10.1016/j.fertnstert.2007.10.020 PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Horcajadas JA, Mínguez P, Dopazo J, Esteban FJ, Domínguez F, Giudice LC, et al. Controlled Ovarian Stimulation Induces a Functional Genomic Delay of the Endometrium with Potential Clinical Implications. J Clin Endocrinol Metab. 2008;93:4500–10. Available from: https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.2008-0588 .CrossRefGoogle Scholar
  33. 33.
    Simon C, Oberye J, Bellver J, Vidal C, Bosch E, Horcajadas JA, et al. Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles. Hum Reprod. 2005;20:3318–27.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Lessey BA, Salamonsen LA, Simón C, Altmäe S, Macklon NS, Campoy C, et al. Guidelines for the design, analysis and interpretation of ‘omics’ data: focus on human endometrium. Hum Reprod Update. 2013;20:12–28.PubMedPubMedCentralGoogle Scholar
  35. 35.
    Hu S, Yao G, Wang Y, Xu H, Ji X, He Y, et al. Transcriptomic changes during the pre-receptive to receptive transition in human endometrium detected by RNA-Seq. J Clin Endocrinol Metab. 2014;99:E2744–53.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Ganesh A, Chauhan N, Das S, Chakravarty B, Chaudhury K. Endometrial receptivity markers in infertile women stimulated with letrozole compared with clomiphene citrate and natural cycles. Syst Biol Reprod Med. 2014;60:105–11.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Miller PB, Parnell BA, Bushnell G, Tallman N, Forstein DA, Higdon HL, et al. Endometrial receptivity defects during IVF cycles with and without letrozole. Hum Reprod. 2012;27:881–8.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    He Z, Ma Y, Li L, Liu J, Yang H, Chen C, et al. Osteopontin and Integrin αvβ3 Expression during the Implantation Window in IVF Patients with Elevated Serum Progesterone and Oestradiol Level. Geburtshilfe Frauenheilkd. 2016;76:709–17.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Liu Y, Kodithuwakku SP, Ng PY, Chai J, Ng EHY, Yeung WSB, et al. Excessive ovarian stimulation up-regulates the Wnt-signaling molecule DKK1 in human endometrium and may affect implantation: An in vitro co-culture study. Hum Reprod. 2010;25:479–90.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Mebratu Y, Tesfaigzi Y. How ERK1/2 Activation Controls Cell Proliferation and Cell Death Is Subcellular Localization the Answer? Cell Cycle. 2010;8:1168–75.CrossRefGoogle Scholar
  41. 41.
    Arlier S, Murk W, Guzeloglu-Kayisli O, Semerci N, Larsen K, Tabak MS, et al. The extracellular signal-regulated kinase 1/2 triggers angiogenesis in human ectopic endometrial implants by inducing angioblast differentiation and proliferation. Am J Reprod Immunol. 2017;78:1–11.CrossRefGoogle Scholar
  42. 42.
    Fluhr H, Spratte J, Bredow M, Heidrich S, Zygmunt M. Constitutive activity of Erk1/2 and NF-κB protects human endometrial stromal cells from death receptor-mediated apoptosis. Reprod Biol [Internet]. Society for Biology of Reproduction and; the Institute of Animal Reproduction and Food Research of Polish Academy of Sciences in Olsztyn; 2013;13:113–21. Available from:  https://doi.org/10.1016/j.repbio.2013.03.001 PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Wang Z, Gerstein M, Snyder M. RNA-Seq : a revolutionary tool for transcriptomics. Nature Reviews Genetics. 2010;10(1):57–63.CrossRefGoogle Scholar
  44. 44.
    Jemt A, Sigurgeirsson B, Hanna A, Ujvari D, Westgren M, Lundeberg J. Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle. Biol Reprod. 2016;96:24–33. Available from: https://academic.oup.com/biolreprod/article/96/1/24/2725477/Comprehensive-RNA-sequencing-of-healthy-human .
  45. 45.
    Ganesh V, Venkatesan V, Koshy T, Nellapalli S, Muthumuthiah S, Franklin S, et al. Systems Biology in Reproductive Medicine Association of estrogen , progesterone and follicle stimulating hormone receptor polymorphisms with in vitro fertilization outcomes. Syst Biol Reprod Med. Taylor & Francis; 2018;64:260–5.  https://doi.org/10.1080/19396368.2018.1482030 PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    Paskulin DD, Cunha-filho JS, Paskulin LD, Augusto C, Souza B, Ashton-prolla P. ESR1 rs9340799 Is Associated with Endometriosis-Related Infertility and In Vitro Fertilization Failure. 2013;35:907–13.Google Scholar
  47. 47.
    Swaminathan M, Ganesh V, Koshy T, et al. A Study on the Role of Estrogen Receptor Gene Polymorphisms in Female Infertility. Genetic Testing and Molecular Biomarkers. 2016;20(11):692–5.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Biosciences M, Medicine V, Li S, Neill SRSO, Zhang Y, Holtzman MJ, et al. Estrogen receptor a is required for oviductal transport of embryos. :1595–607.Google Scholar
  49. 49.
    Pan H, Suo P, Liu C, Wang J, Zhou S, Ma X, et al. The ESR1 gene in unexplained recurrent spontaneous abortion. Syst Biol Reprod Med. 2014;60:161–4.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Boudjenah R, Molina-gomes D, Torre A, Bergere M, Bailly M, Wainer R, et al. Genetic Polymorphisms Influence the Ovarian Response to rFSH Stimulation in Patients Undergoing In Vitro Fertilization Programs with ICSI. 2012;7.Google Scholar
  51. 51.
    De Mattos CS, Trevisan CM, Peluso C, Adami F, Cordts EB, Christofolini DM, et al. ESR1 and ESR2 gene polymorphisms are associated with human reproduction outcomes in Brazilian women. J Ovarian Res. 2014;7:1–9.CrossRefGoogle Scholar
  52. 52.
    Wu X, Pan Y. Molecular characterization, mapping, and haplotype analysis of porcine matrix metalloproteinase genes MMP1 and MMP10. Biochem Genet. 2009;47:763–74.PubMedCrossRefPubMedCentralGoogle Scholar
  53. 53.
    Quintero-Ronderos P, Mercier E, Fukuda M, Suarez C, Gonzalez R, Patarroyo M, et al. Novel genes and mutations in patients affected by recurrent spontaneous abortion. PLoS One. 2017;Submitted:1–14.Google Scholar
  54. 54.
    Kim MS, Yu JH, Lee MY, Kim AL, Jo MH, Kim MG, et al. Differential expression of extracellular matrix and adhesion molecules in fetalorigin amniotic epithelial cells of preeclamptic pregnancy. PLoS One. 2016;11:1–16.Google Scholar
  55. 55.
    Kaartokallio T, Cervera A, Kyllönen A, Laivuori K, Kere J, Laivuori H. Gene expression profiling of pre-eclamptic placentae by RNA sequencing. Sci Rep [Internet]. Nature Publishing Group; 2015;5:1–15. Available from:  https://doi.org/10.1038/srep14107
  56. 56.
    Davidson LM, Coward K. Molecular mechanisms of membrane interaction at implantation [J]. Birth Defects Research Part C: Embryo Today: Reviews. 2016;108(1):19–32.CrossRefGoogle Scholar
  57. 57.
    Shi X, Guo X, Li X, Wang M, Qin R. Loss of Linc01060 induces pancreatic cancer progression through vinculin-mediated focal adhesion turnover. Cancer Lett. 2018;433:76–85.PubMedCrossRefPubMedCentralGoogle Scholar
  58. 58.
    Sohn SJ, Sarvis BK, Cado D, Winoto A. ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression. J Biol Chem. 2002;277:43344–51.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Evans J, Salamonsen LA, Winship A, Menkhorst E, Nie G, Gargett CE, et al. Fertile ground : human endometrial programming and lessons in health and disease. Nat Publ Gr [Internet]. Nature Publishing Group; 2016;12:654–67. Available from:  https://doi.org/10.1038/nrendo.2016.116 PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Medical Center for Human Reproduction, Beijing Chao-Yang HospitalCapital Medical UniversityBeijingChina
  2. 2.Beijing NeoAntigen Biotechnology Co. LtdBeijingChina

Personalised recommendations